Lund D P, Murphy E U
Department of Surgery, Children's Hospital, Boston, MA 02115.
J Pediatr Surg. 1994 Aug;29(8):1130-3; discussion 1133-4. doi: 10.1016/0022-3468(94)90294-1.
Perforated appendicitis in children continues to be associated with significant morbidity. In 1976, a treatment algorithm was begun at the authors' institution, which included immediate appendectomy, antibiotic irrigation of the peritoneal cavity, transperitoneal drainage through the wound, and 10-day treatment with intravenous ampicillin, clindamycin, and gentamicin. Initial results with this scheme in 143 patients demonstrated a 7.7% incidence of major complications and no deaths. From 1981 through 1991, the authors continued to use this treatment plan in all patients with perforated appendicitis. Three hundred seventy-three patients with perforated appendicitis were treated, and the rate of major complications was 6.4%. Infectious complications occurred in 18 patients (4.8%) and included intraabdominal abscesses (5 patients, 1.3%), phlegmon treated with an extended course of antibiotics (6 patients, 1.6%), wound infections (5 patients, 1.3%), and enterocutaneous fistula requiring further operations (2 patients, 0.5%). There were six cases of small bowel obstruction (1.6%), which required operative intervention. There were no deaths. The average length of stay for all patients was 11.4 days (range, 8 to 66 days). Utilization of transperitoneal drainage and choice of antibiotic therapy continue to be sources of controversy in the surgical literature. However, the treatment plan used in the present study resulted in the lowest complication rate reported to date, and the authors conclude that this scheme is truly the "gold standard" for treatment of perforated appendicitis. New treatment plans using laparoscopic appendectomy, different or shorter courses of antibiotics, or not using drains should have complication rates that are as low as, or lower than this one to be considered as useful alternatives.
儿童穿孔性阑尾炎仍然与较高的发病率相关。1976年,作者所在机构开始采用一种治疗方案,包括立即进行阑尾切除术、经腹腔抗生素灌洗、经伤口进行经腹腔引流,以及静脉注射氨苄西林、克林霉素和庆大霉素进行为期10天的治疗。该方案应用于143例患者的初步结果显示,严重并发症的发生率为7.7%,且无死亡病例。从1981年到1991年,作者继续对所有穿孔性阑尾炎患者使用该治疗方案。共治疗了373例穿孔性阑尾炎患者,严重并发症的发生率为6.4%。18例患者(4.8%)发生感染性并发症,包括腹腔内脓肿(5例,1.3%)、经延长疗程抗生素治疗的蜂窝织炎(6例,1.6%)、伤口感染(5例,1.3%)以及需要进一步手术的肠皮肤瘘(2例,0.5%)。有6例小肠梗阻(1.6%),需要手术干预。无死亡病例。所有患者的平均住院时间为11.4天(范围为8至66天)。经腹腔引流的应用和抗生素治疗的选择在外科文献中仍然是有争议的问题。然而,本研究中使用的治疗方案导致了迄今为止报道的最低并发症发生率,作者得出结论,该方案确实是治疗穿孔性阑尾炎的“金标准”。采用腹腔镜阑尾切除术、不同或更短疗程抗生素或不使用引流管的新治疗方案,其并发症发生率应与该方案一样低或更低,才能被视为有用的替代方案。